Innova Captab Limited

Innova Captab Limited (INNOVACAP) is a small-cap Healthcare company valued at ₹5,840 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Innova Captab Limited last traded at ₹1,025.1, modestly up 0.13% on the day.

Recent developments

2026-08-30: The company reported FY26 earnings, with revenue reaching ₹1,630 crores, and Jammu nearing EBITDA breakeven. 2026-08-21: The company is set to report its June quarter results, amid a drop in Manipal Health's profit, which has put it in the spotlight.

Financial performance

The company's business has improved, with annual revenue rising 31.0% and annual net profit increasing 11.9%. The latest quarter saw revenue and net profit both grow significantly, rising 33.8% and 42.4% respectively compared to the same quarter a year earlier. However, the net profit margin narrowed by 1.5 percentage points to 8.8%, and return on equity remained at 0.0%.

Valuation multiples

The stock trades at 55.2 times earnings, a premium to the Healthcare median of 32.0, 6.12 times book value. It yields 0.2%.

Things to watch

The company's return on equity is at 0.0%, indicating no return to shareholders. The stock is 13.7% below its 52-week high, and domestic institutional holding decreased by 0.22 percentage points in the quarter.

Where it stands

Innova Captab Ltd has shown strong revenue and profit growth over the past year and quarter, with revenue growing 31.0% and net profit rising 11.9%. The latest quarter saw significant growth in both revenue and net profit, but the net profit margin narrowed. The stock is currently 13.7% below its 52-week high, and return on equity remains at 0.0%.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.